Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 84%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,958
Total Claims
$2.8M
Drug Cost
529
Beneficiaries
$5,246
Cost/Patient
Risk Score Breakdown 66/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
+3128%
Opioid rate vs peers
42.2% vs 1.3% avg
+30%
Cost per patient vs peers
$5,246 vs $4,034 avg
+81%
Brand preference vs peers
17.0% vs 9.4% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
42.2%
Opioid Rate
5,471
Opioid Claims
$1.1M
Opioid Cost
38.5%
Long-Acting Rate
This provider's opioid prescribing rate of 42.2% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 2,203 claims · $2.0M
Generic: 10,740 claims · $733K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 2,410 | $348K |
| Oxycodone Myristate | 581 | $332K |
| Immun Glob G(Igg)/Gly/Iga Ov50 | 15 | $207K |
| Oxycodone Hcl | 339 | $196K |
| Valbenazine Tosylate | 19 | $162K |
| Semaglutide | 150 | $159K |
| Glatiramer Acetate | 24 | $150K |
| Linaclotide | 203 | $119K |
| Rimegepant Sulfate | 50 | $88K |
| Cariprazine Hcl | 42 | $65K |
| Dimethyl Fumarate | 34 | $65K |
| Plecanatide | 110 | $64K |
| Tirzepatide | 47 | $53K |
| Ubrogepant | 43 | $48K |
| Oxycodone Hcl/Acetaminophen | 16 | $43K |
Prescribing Profile
Patient Profile
61
Avg Age
61%
Female
1.66
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About